Entovis Pacemaker System With ProMRI Technology

First MR conditional pacemaker portfolio in the U.S. with single- and dual-chamber pacemakers


May 8, 2014
Biotronik Entovis Pacemaker Syster MRI FDA Approval

Biotronik's Entovis pacemaker system with ProMRI technology allows patients to undergo magnetic resonance imaging (MRI) scans with a limited exclusion zone. The Entovis system presents advantages over existing pacemakers approved as MR conditional. Patients with approved Entovis pacemakers and leads need only alert radiology staff of their device and the staff will verify the patient meets the criteria to undergo an MRI scan.

Entovis devices include Biotronik Home Monitoring technology, which provides daily monitoring of the patient’s device, and offer the most advanced physiological therapy available via closed loop stimulation (CLS). The Setrox active-fixation pacing leads have a flexible distal end, fractal coating, and steroid elution to ensure excellent handling and stable fixation, as well as optimal electrical performance.

The system received FDA approval in May 2014.

For more information: www.biotronik.com